# TAP Real Estate Technologies, Inc.: financial statements, quarterly

RWAX · OTC · CIK 1119190 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rwax.md) · [Financials](/companies/rwax/financials.md) · [Filings](/companies/rwax/filings.md) · [Insiders](/companies/rwax/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rwax/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.1](/filings/0001493152-24-046795.md) | [0.7 d](/filings/0001493152-24-011766.md) | [0.3](/filings/0001493152-24-020689.md) | [0.2](/filings/0001493152-24-033107.md) | [0.1](/filings/0001493152-24-046795.md) | [(0.4) d](/filings/0001493152-26-013966.md) | [0.0](/filings/0001493152-26-022716.md) | [0.0 d](/filings/0001493152-26-037332.md) | [0.0 d](/filings/0001493152-25-023386.md) | [0.0 d](/filings/0001493152-26-013966.md) | [0.0](/filings/0001493152-26-022716.md) | [0.0 d](/filings/0001493152-26-037332.md) |
| Cost of revenue | $m | [0.0](/filings/0001493152-24-046795.md) | [0.2 d](/filings/0001493152-24-011766.md) | [0.3](/filings/0001493152-24-020689.md) | [0.2](/filings/0001493152-24-033107.md) | [0.0](/filings/0001493152-24-046795.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | [0.1](/filings/0001493152-24-046795.md) | [0.5 d](/filings/0001493152-24-011766.md) | [0.0](/filings/0001493152-24-020689.md) | [(0.0)](/filings/0001493152-24-033107.md) | [0.1](/filings/0001493152-24-046795.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(4.6)](/filings/0001493152-24-046795.md) | [0.9 d](/filings/0001641172-25-009520.md) | [(1.5)](/filings/0001641172-25-013874.md) | [(1.5)](/filings/0001641172-25-023774.md) | [(1.1)](/filings/0001493152-25-023386.md) | [(4.2) d](/filings/0001493152-26-013966.md) | [(1.4)](/filings/0001493152-26-022716.md) | [(1.9)](/filings/0001493152-26-037332.md) | [(3.0)](/filings/0001493152-25-023386.md) | [(1.4) d](/filings/0001493152-26-013966.md) | [(1.8)](/filings/0001493152-26-022716.md) | [(1.0)](/filings/0001493152-26-037332.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.5](/filings/0001641172-25-013874.md) | [0.0 d](/filings/0001641172-25-023774.md) | [0.0 d](/filings/0001493152-25-023386.md) | [0.0 d](/filings/0001493152-26-013966.md) | not reported | not reported |
| Net income | $m | [(5.8)](/filings/0001493152-24-046795.md) | [(5.4) d](/filings/0001641172-25-009520.md) | [(0.2)](/filings/0001493152-25-023386.md) | [(2.7)](/filings/0001493152-25-023386.md) | [(2.3)](/filings/0001493152-25-023386.md) | [(9.2) d](/filings/0001493152-26-013966.md) | [12.8](/filings/0001493152-26-037332.md) | [(2.8)](/filings/0001493152-26-037332.md) | [(17.1)](/filings/0001493152-25-023386.md) | [(8.2) d](/filings/0001493152-26-013966.md) | [(3.0)](/filings/0001493152-26-037332.md) | [(1.5)](/filings/0001493152-26-037332.md) |
| Diluted EPS | $ per share | [0.00](/filings/0001493152-24-046795.md) | not reported | [0.00](/filings/0001641172-25-013874.md) | [0.00](/filings/0001641172-25-023774.md) | [0.00](/filings/0001493152-25-023386.md) | not reported | [0.00](/filings/0001493152-26-022716.md) | [0.00](/filings/0001493152-26-037332.md) | [0.00](/filings/0001493152-25-023386.md) | not reported | [0.00](/filings/0001493152-26-022716.md) | [0.00](/filings/0001493152-26-037332.md) |
| Basic EPS | $ per share | [0.00](/filings/0001493152-24-046795.md) | not reported | [0.00](/filings/0001641172-25-013874.md) | [0.00](/filings/0001641172-25-023774.md) | [0.00](/filings/0001493152-25-023386.md) | not reported | [0.00](/filings/0001493152-26-022716.md) | [0.00](/filings/0001493152-26-037332.md) | [0.00](/filings/0001493152-25-023386.md) | not reported | [0.00](/filings/0001493152-26-022716.md) | [0.00](/filings/0001493152-26-037332.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.1](/filings/0001493152-23-040481.md) | [0.4](/filings/0001641172-25-009520.md) | [0.0](/filings/0001493152-24-020689.md) | [0.0](/filings/0001493152-24-033107.md) | [0.3](/filings/0001493152-24-046795.md) | [0.0](/filings/0001493152-26-013966.md) | [2.1](/filings/0001641172-25-013874.md) | [0.1](/filings/0001641172-25-023774.md) | [0.0](/filings/0001493152-25-023386.md) | [0.1](/filings/0001493152-26-037332.md) | [0.0](/filings/0001493152-26-022716.md) | [0.2](/filings/0001493152-26-037332.md) |
| Current assets | $m | [0.6](/filings/0001493152-23-040481.md) | [0.8](/filings/0001641172-25-009520.md) | [3.1](/filings/0001493152-24-020689.md) | [3.1](/filings/0001493152-24-033107.md) | [3.3](/filings/0001493152-24-046795.md) | [3.0](/filings/0001493152-26-013966.md) | [19.0](/filings/0001641172-25-013874.md) | [16.5](/filings/0001641172-25-023774.md) | [1.2](/filings/0001493152-25-023386.md) | [1.4](/filings/0001493152-26-037332.md) | [1.5](/filings/0001493152-26-022716.md) | [1.8](/filings/0001493152-26-037332.md) |
| Total assets | $m | [1.3](/filings/0001493152-23-040481.md) | [1.5](/filings/0001641172-25-009520.md) | [3.4](/filings/0001493152-24-020689.md) | [3.3](/filings/0001493152-24-033107.md) | [3.5](/filings/0001493152-24-046795.md) | [23.2](/filings/0001493152-26-013966.md) | [39.0](/filings/0001641172-25-013874.md) | [36.5](/filings/0001641172-25-023774.md) | [21.2](/filings/0001493152-25-023386.md) | [1.4](/filings/0001493152-26-037332.md) | [2.2](/filings/0001493152-26-022716.md) | [2.5](/filings/0001493152-26-037332.md) |
| Current liabilities | $m | [7.7](/filings/0001493152-23-040481.md) | [5.5](/filings/0001641172-25-009520.md) | [5.2](/filings/0001493152-24-020689.md) | [4.7](/filings/0001493152-24-033107.md) | [5.2](/filings/0001493152-24-046795.md) | [26.7](/filings/0001493152-26-013966.md) | [25.6](/filings/0001641172-25-013874.md) | [24.2](/filings/0001641172-25-023774.md) | [3.7](/filings/0001493152-25-023386.md) | [4.2](/filings/0001493152-26-037332.md) | [5.1](/filings/0001493152-26-022716.md) | [5.1](/filings/0001493152-26-037332.md) |
| Total liabilities | $m | [13.6](/filings/0001493152-23-040481.md) | [5.6](/filings/0001641172-25-009520.md) | [5.2](/filings/0001493152-24-020689.md) | [5.0](/filings/0001493152-24-033107.md) | [5.6](/filings/0001493152-24-046795.md) | [26.7](/filings/0001493152-26-013966.md) | [25.6](/filings/0001641172-25-013874.md) | [24.2](/filings/0001641172-25-023774.md) | [3.7](/filings/0001493152-25-023386.md) | [4.2](/filings/0001493152-26-037332.md) | [5.1](/filings/0001493152-26-022716.md) | [5.1](/filings/0001493152-26-037332.md) |
| Shareholders' equity | $m | [(12.4)](/filings/0001493152-24-046795.md) | [(4.1)](/filings/0001493152-26-013966.md) | [(1.8)](/filings/0001493152-25-023386.md) | [(1.4)](/filings/0001493152-25-023386.md) | [(1.7)](/filings/0001493152-25-023386.md) | [(3.5)](/filings/0001493152-26-037332.md) | [13.4](/filings/0001493152-26-037332.md) | [12.3](/filings/0001493152-26-037332.md) | [17.6](/filings/0001493152-25-023386.md) | [(2.9)](/filings/0001493152-26-037332.md) | [(2.9)](/filings/0001493152-26-037332.md) | [(2.6)](/filings/0001493152-26-037332.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(858) d](/filings/0001493152-24-046795.md) | [(1,159) d](/filings/0001641172-25-009520.md) | [(808)](/filings/0001641172-25-013874.md) | [(533) d](/filings/0001641172-25-023774.md) | [(496) d](/filings/0001493152-25-023386.md) | [(1,347) d](/filings/0001493152-26-013966.md) | [(298)](/filings/0001493152-26-022716.md) | [(1,129) d](/filings/0001493152-26-037332.md) | [(120) d](/filings/0001493152-25-023386.md) | [(109) d](/filings/0001493152-26-013966.md) | [(389)](/filings/0001493152-26-022716.md) | [(211) d](/filings/0001493152-26-037332.md) |
| Capital expenditure | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported

## Shares

| Line item | Unit | period not labelled (2022-03-31) | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | billions of shares | [1.2](/filings/0001493152-23-017257.md) | [1.5](/filings/0001493152-23-028641.md) | [1.7](/filings/0001493152-23-040481.md) | [7.0](/filings/0001493152-23-017257.md) | [1.5](/filings/0001493152-23-028641.md) | [5.5](/filings/0001493152-23-040481.md) | [12.2](/filings/0001641172-25-013874.md) | [14.7](/filings/0001641172-25-023774.md) | [18.2](/filings/0001493152-25-023386.md) | [45.6](/filings/0001641172-25-013874.md) | [41.1](/filings/0001641172-25-023774.md) | [46.3](/filings/0001493152-25-023386.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 61,921,332,657 at 2026-08-12, from the cover of the [10-Q filed 2026-08-12](/filings/0001493152-26-037332.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:33 ET. No prices; not investment advice.